Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Leukine (Sargramostim) for Parkinson's Disease

This study is currently recruiting participants. (see Contacts and Locations)
Verified September 2014 by University of Nebraska
Sponsor:
Collaborators:
Sanofi
UNeMed
Nebraska Neuroscience Alliance
Information provided by (Responsible Party):
Howard Gendelman, MD, University of Nebraska Medical Center
ClinicalTrials.gov Identifier:
NCT01882010
First received: June 13, 2013
Last updated: September 17, 2014
Last verified: September 2014
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: September 2016
  Estimated Primary Completion Date: September 2015 (Final data collection date for primary outcome measure)